Show simple item record

Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults.

dc.contributor.authorayitenkore, K
dc.contributor.authorOmosa-Manyonyi, G
dc.contributor.authorBwayo, J
dc.contributor.authorKarita, E
dc.contributor.authorJaoko, WG
dc.contributor.authorSchmidt, C
dc.contributor.authorGilmour, J
dc.contributor.authorBoaz, M
dc.contributor.authorThan, S
dc.contributor.authorGraham, B
dc.date.accessioned2013-12-02T12:30:25Z
dc.date.available2013-12-02T12:30:25Z
dc.date.issued2007
dc.identifier.citationayitenkore K, Omosa-Manyonyi G, Bwayo J, Karita E, Jaoko WG, Schmidt C, Gilmour J, Boaz M, Than S & Graham B (2007) Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults. CROI, Los Angeles, USAen
dc.identifier.urihttp://hdl.handle.net/11295/61436
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleSafety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults.en
dc.typePresentationen
local.publisherSchool of Medicineen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record